Anti-NPC2/ EDDM1/ HE1 functional antibody

Anti-NPC2/ EDDM1/ HE1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NPC2/NPC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1133-Ab-1/ GM-Tg-hg-SE1133-Ab-2Anti-Human NPC2 monoclonal antibodyHuman
GM-Tg-rg-SE1133-Ab-1/ GM-Tg-rg-SE1133-Ab-2Anti-Rat NPC2 monoclonal antibodyRat
GM-Tg-mg-SE1133-Ab-1/ GM-Tg-mg-SE1133-Ab-2Anti-Mouse NPC2 monoclonal antibodyMouse
GM-Tg-cynog-SE1133-Ab-1/ GM-Tg-cynog-SE1133-Ab-2Anti-Cynomolgus/ Rhesus macaque NPC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1133-Ab-1/ GM-Tg-felg-SE1133-Ab-2Anti-Feline NPC2 monoclonal antibodyFeline
GM-Tg-cang-SE1133-Ab-1/ GM-Tg-cang-SE1133-Ab-2Anti-Canine NPC2 monoclonal antibodyCanine
GM-Tg-bovg-SE1133-Ab-1/ GM-Tg-bovg-SE1133-Ab-2Anti-Bovine NPC2 monoclonal antibodyBovine
GM-Tg-equg-SE1133-Ab-1/ GM-Tg-equg-SE1133-Ab-2Anti-Equine NPC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1133-Ab-1/ GM-Tg-hg-SE1133-Ab-2; GM-Tg-rg-SE1133-Ab-1/ GM-Tg-rg-SE1133-Ab-2;
GM-Tg-mg-SE1133-Ab-1/ GM-Tg-mg-SE1133-Ab-2; GM-Tg-cynog-SE1133-Ab-1/ GM-Tg-cynog-SE1133-Ab-2;
GM-Tg-felg-SE1133-Ab-1/ GM-Tg-felg-SE1133-Ab-2; GM-Tg-cang-SE1133-Ab-1/ GM-Tg-cang-SE1133-Ab-2;
GM-Tg-bovg-SE1133-Ab-1/ GM-Tg-bovg-SE1133-Ab-2; GM-Tg-equg-SE1133-Ab-1/ GM-Tg-equg-SE1133-Ab-2
Products NameAnti-NPC2 monoclonal antibody
Formatmab
Target NameNPC2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NPC2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1133-Ag-1Recombinant multi-species NPC2/ EDDM1/ HE1 protein
    ORF Viral VectorpGMLP002951human NPC2 Lentivirus plasmid
    ORF Viral VectorvGMLP002951human NPC2 Lentivirus particle
    ORF Viral VectorpGMLPm001885mouse Npc2 Lentivirus plasmid
    ORF Viral VectorvGMLPm001885mouse Npc2 Lentivirus particle


    Target information

    Target IDGM-SE1133
    Target NameNPC2
    Gene ID10577,67963,286898,699881,403920,101094270,280815,100051060
    Gene Symbol and Synonyms2700012J19Rik,CE1,EDDM1,HE1,NPC2,re1
    Uniprot AccessionP61916,Q28895,P79345
    Uniprot Entry NameNPC2_HUMAN,NPC2_CANLF,NPC2_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000119655
    Target ClassificationN/A

    The target: NPC2, gene name: NPC2, also named as EDDM1, HE1. This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.